Alterity Therapeutics ltd Insider Trading
ATHE
Insiders bought 24K on the open market and sold nothing.
Get an email when ATHE's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31 | Peter Ashley Marks Director | Bought | 47,620 | $0.50 | 24K | 33% | Form 4 |
- Aug 31Peter Ashley MarksDirector · bought 47,620 at $0.5024K33% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with ATHE
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ATHE
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.